Ovarian Hyperstimulation Syndrome: Experience of a Reproductive Medicine Center 2005-2011

Detalhes bibliográficos
Autor(a) principal: Lima, Mariana
Data de Publicação: 2013
Outros Autores: Sousa, Mário, Oliveira, Cristiano, Silva, Joaquina, Teixeira Da Silva, José, Cunha, Mariana, Viana, Paulo, Barros, Alberto
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4008
Resumo: Introduction: Ovarian Hyperstimulation Syndrome is a complication of controlled ovarian hyperstimulation during cycles of Assisted Medical Reproduction. The objective of this work was to analyze those cycles to achieve a better knowledge of this pathology, namely risk factors and strategies for prevention and treatment of Ovarian Hyperstimulation Syndrome . Materials and Methods: Retrospective analysis of 4870 ART cycles (2005 - 2011), with moderate (27) and severe (24) Ovarian Hyperstimulation Syndrome . Data was analyzed for patients’ characteristics, stimulation protocol, embryologic and clinical outcomes, and treatment performed. Results: In Ovarian Hyperstimulation Syndrome groups the mean ages and the doses of rFSH + HMG were lower, and the serum E2 levels, doses of HCG, number of oocytes retrieved as well as the rates of blastocyst, biochemical and clinical pregnancy, implantation, newborns, very preterm birth and newborns with low and very low weight were significantly higher. Patients with severe Ovarian Hyperstimulation Syndrome were hospitalized and received only support measures with no complications. Discussion: Ovarian Hyperstimulation Syndrome is associated with conditions that can bring risk to the fetus, namely prematurity and low birth weight, so the pregnancy should be carefully monitored in these cases. Conclusions: Young age is a risk factor for Ovarian Hyperstimulation Syndrome and high serum E2 levels may predict a higher risk too and thus should induce the adoption of prevention strategies.
id RCAP_2a86ba94878953dd0027af1b9bb92449
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/4008
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str
spelling Ovarian Hyperstimulation Syndrome: Experience of a Reproductive Medicine Center 2005-2011Síndrome de Hiperestimulação Ovárica: Experiência de um Centro de Medicina da Reprodução 2005-2011Introduction: Ovarian Hyperstimulation Syndrome is a complication of controlled ovarian hyperstimulation during cycles of Assisted Medical Reproduction. The objective of this work was to analyze those cycles to achieve a better knowledge of this pathology, namely risk factors and strategies for prevention and treatment of Ovarian Hyperstimulation Syndrome . Materials and Methods: Retrospective analysis of 4870 ART cycles (2005 - 2011), with moderate (27) and severe (24) Ovarian Hyperstimulation Syndrome . Data was analyzed for patients’ characteristics, stimulation protocol, embryologic and clinical outcomes, and treatment performed. Results: In Ovarian Hyperstimulation Syndrome groups the mean ages and the doses of rFSH + HMG were lower, and the serum E2 levels, doses of HCG, number of oocytes retrieved as well as the rates of blastocyst, biochemical and clinical pregnancy, implantation, newborns, very preterm birth and newborns with low and very low weight were significantly higher. Patients with severe Ovarian Hyperstimulation Syndrome were hospitalized and received only support measures with no complications. Discussion: Ovarian Hyperstimulation Syndrome is associated with conditions that can bring risk to the fetus, namely prematurity and low birth weight, so the pregnancy should be carefully monitored in these cases. Conclusions: Young age is a risk factor for Ovarian Hyperstimulation Syndrome and high serum E2 levels may predict a higher risk too and thus should induce the adoption of prevention strategies.Introdução: A Síndrome de Hiperestimulação Ovárica é uma complicação da hiperestimulação controlada do ovário realizada nos ciclos de reprodução medicamente assistida . O objetivo deste trabalho foi efetuar uma análise desses ciclos, para melhor compreensão daquela patologia, nomeadamente fatores de risco, formas de prevenção e tratamento da mesma e suas consequências. Materiais e Métodos: Análise retrospetiva de 4870 ciclos de reprodução medicamente assistida (2005 - 2011) com Síndrome de Hiperestimulação moderado (27) e grave (24). Foram estudados, os dados das características dos doentes, protocolos de estimulação, resultados embriológicos e clínicos, e tratamento efetuado. Resultados: No grupo com Síndrome de Hiperestimulação Ovárica a idade média foi inferior, a dose de rFSH + HMG foi mais baixa e os níveis de estradiol foram mais elevados. Nos grupos com Síndrome de Hiperestimulação, as taxas foram significativamente superiores para o número médio de ovócitos e blastocistos obtidos, de gravidez bioquímica e clínica, de implantação e de recém-nascidos. O parto muito pré-termo e a proporção de recém-nascidos com peso baixo e muito baixo foram superiores no grupo com Síndrome de Hiperestimulação Ovárica. As doentes com Síndrome de Hiperestimulação Ovárica grave foram hospitalizadas tendo apenas sido necessária medicação de suporte. Discussão: A Síndrome de Hiperestimulação Ovárica foi associada a condições de risco para o feto, nomeadamente prematuridade e baixo peso ao nascimento, devendo manter-se uma vigilância apertada da gravidez nestes casos. Conclusão: A idade jovem constitui um fator de risco de Síndrome de Hiperestimulação Ovárica e o nível de estradiol elevado foi preditor do mesmo, devendo levar à adoção de estratégias de prevenção.Ordem dos Médicos2013-04-24info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4008oai:ojs.www.actamedicaportuguesa.com:article/4008Acta Médica Portuguesa; Vol. 26 No. 1 (2013): January-February; 24-32Acta Médica Portuguesa; Vol. 26 N.º 1 (2013): Janeiro-Fevereiro; 24-321646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4008https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4008/3206https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4008/4128Lima, MarianaSousa, MárioOliveira, CristianoSilva, JoaquinaTeixeira Da Silva, JoséCunha, MarianaViana, PauloBarros, Albertoinfo:eu-repo/semantics/openAccess2022-12-20T11:03:12ZPortal AgregadorONG
dc.title.none.fl_str_mv Ovarian Hyperstimulation Syndrome: Experience of a Reproductive Medicine Center 2005-2011
Síndrome de Hiperestimulação Ovárica: Experiência de um Centro de Medicina da Reprodução 2005-2011
title Ovarian Hyperstimulation Syndrome: Experience of a Reproductive Medicine Center 2005-2011
spellingShingle Ovarian Hyperstimulation Syndrome: Experience of a Reproductive Medicine Center 2005-2011
Lima, Mariana
title_short Ovarian Hyperstimulation Syndrome: Experience of a Reproductive Medicine Center 2005-2011
title_full Ovarian Hyperstimulation Syndrome: Experience of a Reproductive Medicine Center 2005-2011
title_fullStr Ovarian Hyperstimulation Syndrome: Experience of a Reproductive Medicine Center 2005-2011
title_full_unstemmed Ovarian Hyperstimulation Syndrome: Experience of a Reproductive Medicine Center 2005-2011
title_sort Ovarian Hyperstimulation Syndrome: Experience of a Reproductive Medicine Center 2005-2011
author Lima, Mariana
author_facet Lima, Mariana
Sousa, Mário
Oliveira, Cristiano
Silva, Joaquina
Teixeira Da Silva, José
Cunha, Mariana
Viana, Paulo
Barros, Alberto
author_role author
author2 Sousa, Mário
Oliveira, Cristiano
Silva, Joaquina
Teixeira Da Silva, José
Cunha, Mariana
Viana, Paulo
Barros, Alberto
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Lima, Mariana
Sousa, Mário
Oliveira, Cristiano
Silva, Joaquina
Teixeira Da Silva, José
Cunha, Mariana
Viana, Paulo
Barros, Alberto
description Introduction: Ovarian Hyperstimulation Syndrome is a complication of controlled ovarian hyperstimulation during cycles of Assisted Medical Reproduction. The objective of this work was to analyze those cycles to achieve a better knowledge of this pathology, namely risk factors and strategies for prevention and treatment of Ovarian Hyperstimulation Syndrome . Materials and Methods: Retrospective analysis of 4870 ART cycles (2005 - 2011), with moderate (27) and severe (24) Ovarian Hyperstimulation Syndrome . Data was analyzed for patients’ characteristics, stimulation protocol, embryologic and clinical outcomes, and treatment performed. Results: In Ovarian Hyperstimulation Syndrome groups the mean ages and the doses of rFSH + HMG were lower, and the serum E2 levels, doses of HCG, number of oocytes retrieved as well as the rates of blastocyst, biochemical and clinical pregnancy, implantation, newborns, very preterm birth and newborns with low and very low weight were significantly higher. Patients with severe Ovarian Hyperstimulation Syndrome were hospitalized and received only support measures with no complications. Discussion: Ovarian Hyperstimulation Syndrome is associated with conditions that can bring risk to the fetus, namely prematurity and low birth weight, so the pregnancy should be carefully monitored in these cases. Conclusions: Young age is a risk factor for Ovarian Hyperstimulation Syndrome and high serum E2 levels may predict a higher risk too and thus should induce the adoption of prevention strategies.
publishDate 2013
dc.date.none.fl_str_mv 2013-04-24
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4008
oai:ojs.www.actamedicaportuguesa.com:article/4008
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4008
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/4008
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4008
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4008/3206
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/4008/4128
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 26 No. 1 (2013): January-February; 24-32
Acta Médica Portuguesa; Vol. 26 N.º 1 (2013): Janeiro-Fevereiro; 24-32
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1777301642970923008